ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 60 filers reported holding ONCOCYTE CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15 | -99.8% | 65,123 | +516.8% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | -57.9% | 10,558 | -49.1% | 0.00% | -50.0% |
| Q2 2022 | $19,000 | -78.7% | 20,741 | -44.0% | 0.00% | -80.0% |
| Q4 2020 | $89,000 | +74.5% | 37,030 | +39.7% | 0.01% | +66.7% |
| Q2 2020 | $51,000 | 0.0% | 26,504 | +16.2% | 0.01% | +20.0% |
| Q4 2019 | $51,000 | -55.3% | 22,801 | -21.1% | 0.01% | -16.7% |
| Q1 2019 | $114,000 | – | 28,883 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |